WO2007071038A2 - Compositions comprenant un ou plusieurs phytostérols et/ou phytostanols, ou des dérivés de de ceux-ci, et des émulsifiants à rapport hlb élevé - Google Patents

Compositions comprenant un ou plusieurs phytostérols et/ou phytostanols, ou des dérivés de de ceux-ci, et des émulsifiants à rapport hlb élevé Download PDF

Info

Publication number
WO2007071038A2
WO2007071038A2 PCT/CA2006/002077 CA2006002077W WO2007071038A2 WO 2007071038 A2 WO2007071038 A2 WO 2007071038A2 CA 2006002077 W CA2006002077 W CA 2006002077W WO 2007071038 A2 WO2007071038 A2 WO 2007071038A2
Authority
WO
WIPO (PCT)
Prior art keywords
hlb
sterol
sterols
stanols
emulsifiers
Prior art date
Application number
PCT/CA2006/002077
Other languages
English (en)
Other versions
WO2007071038A3 (fr
Inventor
Jerzy Zawistowski
Original Assignee
Forbes Medi-Tech Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Forbes Medi-Tech Inc. filed Critical Forbes Medi-Tech Inc.
Priority to JP2008546053A priority Critical patent/JP2009519721A/ja
Priority to EP06840504A priority patent/EP1973427A2/fr
Priority to CA002673010A priority patent/CA2673010A1/fr
Priority to AU2006326830A priority patent/AU2006326830A1/en
Publication of WO2007071038A2 publication Critical patent/WO2007071038A2/fr
Publication of WO2007071038A3 publication Critical patent/WO2007071038A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
    • A23C9/1307—Milk products or derivatives; Fruit or vegetable juices; Sugars, sugar alcohols, sweeteners; Oligosaccharides; Organic acids or salts thereof or acidifying agents; Flavours, dyes or pigments; Inert or aerosol gases; Carbonation methods
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
    • A23C9/154—Milk preparations; Milk powder or milk powder preparations containing additives containing thickening substances, eggs or cereal preparations; Milk gels
    • A23C9/1544—Non-acidified gels, e.g. custards, creams, desserts, puddings, shakes or foams, containing eggs or thickening or gelling agents other than sugar; Milk products containing natural or microbial polysaccharides, e.g. cellulose or cellulose derivatives; Milk products containing nutrient fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/10—Foods or foodstuffs containing additives; Preparation or treatment thereof containing emulsifiers
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Definitions

  • TITLE COMPOSITIONS COMPRISING ONE OR MORE PHYTOSTEROLS AND/OR PHYTOSTANOLS, OR DERIVATIVES THEREOF, AND HIGH HLB EMULSIFIERS
  • This present invention relates to the field of compositions comprising specific naturally derived hydrophobic compounds, particularly sterols and stanols of plant or marine origin, and the means by which such sterols or stanols or their esters can be readily incorporated into delivery vehicles such as food, beverages, nutraceuticals and pharmaceuticals.
  • Atherosclerosis is a degenerative process resulting from an interplay of inherited (genetic) factors and environmental factors such as diet and lifestyle.
  • CVD cardiovascular disease
  • Research to date suggest that cholesterol may play a role in atherosclerosis by forming atherosclerotic plaques in blood vessels, ultimately cutting off blood supply to the heart muscle or alternatively to the brain or limbs, depending on the location of the plaque in the arterial tree 1 , 2 .
  • Data from the early Framingham Epidemiological Study indicates that increases in serum cholesterol levels are associated with increased risk of death from CVD 3 . More recent studies confirm that CVD is a leading cause of death and disability in industrialized nations 4 .
  • plant-derived sterols and stands also known as phytosterols and phytostanols.
  • Sterols are naturally occurring compounds that perform many critical cellular functions.
  • Phytosterols such as campesterol, stigmasterol and beta-sitosterol in plants, ergosterol in fungi and cholesterol in animals are each primary components of cellular and sub-cellular membranes in their respective cell types.
  • the dietary source of phytosterols in humans comes from plant materials i.e. vegetables and plant oils.
  • the estimated daily phytosterol content in the conventional western-type diet is approximately 60-80 milligrams in contrast to a vegetarian diet which would provide about 500 milligrams per day.
  • Phytosterols have received a great deal of attention due to their ability to decrease serum cholesterol levels when fed to a number of mammalian species, including humans. While the precise mechanism of action remains largely unknown, the relationship between cholesterol and phytosterols is apparently due in part to the similarities between the respective chemical structures (the differences occurring in the side chains of the molecules). It is assumed that phytosterols displace cholesterol from the micellar phase and thereby reduce its absorption or possibly compete with receptor and/or carrier sites in the cholesterol absorption process.
  • compositions have been explored in which phytosterols or phytostanols (their hydrogenated counterparts) are est ⁇ rified in order to enhance solubility.
  • phytosterols or phytostanols est ⁇ rified in order to enhance solubility.
  • One composition of phytosterols which has been found to be highly effective in lowering serum cholesterol is disclosed in US Patent Serial No. 5,770,749 to Kutney et al.
  • phytosterols Despite the obvious and now well recorded advantages of phytosterols, not only in the treatment of CVD and its underlying conditions such as hypercholesterolemia, hyperlipidemia, atherosclerosis, hypertension, thrombosis but in the treatment of other diseases such as Type Il diabetes, dementia cancer and aging, the administration of phytosterols and the incorporation thereof into foods, pharmaceuticals and other delivery vehicles has been complicated by the fact that they are highly hydrophobic (i.e. they have poor water solubility). This highly hydrophobic nature of phytosterols renders them insoluble and barely dispersible in aqueous media. As such, phytosterols tend to be added to the fat phase of fat-based food products. Health-conscious consumers wishing to benefit from the cholesterol lowering effects of phytosterols are therefore forced to consume fat- rich foods, despite the health risks of a high fat diet.
  • phytosterols have a waxy consistency and a high melting point, creating solubility issues for the food processor. While they are oil-dispersible to some extent in their raw form, the amount required to produce an efficacious effect in a finished product can cause granulation. The current answer to this problem is esterification, which creates something of an equilibrium between the phytosterols and liquid oil. Due to these physical property limitations of phytosterols, their use by food manufacturers has been limited to fat- based products like margarine, salad dressings and, most recently, snack bars.
  • phytosterols are highly hydrophobic, they do not dissolve to any appreciable extent in the micellar phase in the digestive tract and therefore are not capable of efficiently blocking cholesterol absorption. Oils and fats are capable to a limited but not satisfactory degree of dissolving free phytosterols. Only substantially solubilized phytosterols appear inhibit the absorption of cholesterol.
  • phytosterols have high melting points (typically about 136- 150 0 C) it is important to maintain a temperature of 80 0 C or higher during dissolution of phytosterols in fats or oils, in order to avoid recrystallization of the phytosterols.
  • Crystalline phytosterol imparts an unpleasant grainy, waxy texture to edible and topical products.
  • 80 0 C and above commonly used fats and oils are vulnerable to oxidation. Rancid oils and fats detract greatly from the organoleptic properties of food products in particular. Hence there is a need to address the issue of this waxy texture in order to make any deliverable foods and beverages palatable and marketable.
  • the problems associated with adding phytosterols to the fat phase are compounded in low fat, fat-based products and in non-fat products.
  • the amount of phytosterol capable of being dispersed in the fat phase of a fat-based emulsified product directly correlates with the amount of lipid in the product.
  • the problems posed by the need to disperse phytosterols in fat become more acute the lower the fat content of a fat- based product.
  • phytosterols have been incorporated into food products by melting a sterol or stanol, incorporating it into an oil phase, and blending the oil phase with other components to result in a phytosterol-containing food product.
  • the aforementioed high melting points can result in significant crystallization of the phytosterols within the oil phase of such food products.
  • Such crystallization results in food products with a gritty and unacceptable texture. This gritty texture is especially detectable when the oil/plant sterol phase is incorporated at high levels in the food product.
  • the high melting points and hydrophobic nature of such phytosterols also make it difficult to blend such them with an aqueous phase.
  • actual melting of the plant sterol for incorporation into food products is energy intensive.
  • phytosterol esters generally may be incorporated into food products more readily due to the lower melting points and can provide food products without significantly gritty texture.
  • phytosterol esters are biologically less effective than non-esterified phytosterols; and 2) when a phytosterol or phytosterol ester is distributed within the small volume lipid phase of a low fat emulsified product, the taste of the product is adversely affected, since the high concentration of phytosterol in the fat leads to a waxy sensation in the mouth and on the tongue.
  • European Patent Application EP 0 896 671 A (published February 24, 1999) provides an aqueous dispersion of phytosterols by melting the phytosterols and emulsifiers to form a molten mixture and then dispersing the molten mixture in water using high shear. It was reported "that the step of melting the high melting phytosterols with surfactant prior to dispersion in water with or without surfactant contributes importantly to the ability to prepare a very fine dispersion with the use of high shear mixing or homogenization of the phytosterol or other melting lipid".
  • the phytosterols are reported to have particle sizes of less than 15 microns and preferably less than 10 microns in aqueous dispersions. Such phytosterol dispersions could be incorporated into food products without the grittiness normally associated with phytosterols.
  • Coca Cola attempted to address the issue of incorporating highly hydrophobic compounds, such as phytosterols, into fruit beverages. It is noted in the application that "since hydrophobic ingredients have a different density than water and as a result, at the time of purchase and consumption of the product, a hydrophobic component may separate and float to the surface or sink to the bottom. The hydrophobic component that floats to the surface produces undesirable "ringing," which is found in beverages, such as juices containing a hydrophobic ingredient with a density less than water, and results in a product that is non-uniform throughout the container.” Coca Cola has attempted to solve this problem by creating aqueous sterol dispersions without any added emulsifiers or thickening agents.
  • U. S. Patent No. 6,129,944 describes a method for producing a product containing a plant sterol by forming a homogeneous suspension of a microcrystalline plant sterol and a sweetening agent in an aqueous solution.
  • Vulfson et al., WO 00/41491 discloses hydrophobic compounds such as plant sterols and lycopenes as supplements to food products and beverages such as oleomargarine products, drinks, soups, sauces, dips, salad dressings, mayonnaise, confectionery products, breads, cakes, biscuits, breakfast cereals and yogurt type products.
  • Vulson et al. in combining the plant sterol or lycopene with the food product, theorizes that the food product which has both hydroxyl and carboxyl groups interacts with the surface of the sterol or lycopene.
  • Haarasilta et al., WO 98/58554 describes a premix used in the food industry containing a pulverized plant sterol and a conventional foodstuff ingredient such as fruit, vegetable or berry type of material, particularly in a powder form and methods for preparing the premix.
  • Zawistowski describes a method of preparing microparticles of plant sterols and plant stands or mixtures of both by dispersing and suspending the plant sterols and plant stands in a semi- fluid, fluid or viscous vehicle and exposing the vehicle so formed to impact forces.
  • the method involves dispersing or otherwise suspending the plant sterol and/or plant stanol in a suitable semi-fluid, fluid or viscous vehicle followed by applying impact forces to the vehicle to produce microparticles.
  • Zawistowski develops these impact forces by creating high- shear either with an air atomization nozzle, a pneumatic nozzle, a high-shear mixer, or colloid mill, but preferably a microfluidizer commercially available from Microfluidics Incorporation, Newton, Massachusetts. Zawistowski observed that the plant sterols and/or plant stands prepared in this way have greater "solubility" not only in oil based delivery systems but also in other media and can be incorporated into beverages such as colas, juices or dietary supplement and/or milk replacement drinks.
  • aqueous-dispersible plant sterol is produced by admixing oryzanol or plant sterol, a monofunctional surfactant and polyfunctional surfactant in water at fixed ratios, and drying the admixture.
  • This production method is characterized by being free from homogenization and deaeration steps with adoption of polyoxylene sorbitan monopalmitate and sorbitan monopalmitate as a monofunctional surfactant and a polyfunctional surfactant, respectively.
  • U S Patent No. 6,190,720 discloses a food ingredient that can be used as a cholesterol- lowering agent, teaching that the food ingredient can be prepared by combining one or more molten plant sterols with one or more fats and one or more emulsifiers to homogeneity and cooling the homogeneous mixture to about 60 °C under agitation to give a paste.
  • This food ingredient can be applied to oil-based foods such as salad dressings, margarine, etc.
  • PCT WO 00/33669 teaches that plant sterols can be dissolved or mixed in a melt of a food emulsifier, admixed with protein-containing foods such as milk or yogurt, homogenized, and added to food products.
  • protein-containing foods such as milk or yogurt
  • homogenized protein-containing foods
  • the dispersion stability of the cholesterol reducing, edible products is maintained only in the presence of a protein-containing material.
  • U S Patent No. 6,267,963 describes a plant sterol-emulsifier complex which has a melting temperature at least 30 0 C below that of the plant sterol, characterized in that, due to its reduced melting temperature, the plant sterol-emulsifer is less likely to crystallize during or after the manufacture of food products, and can be incorporated into food products in an amount effective to reduce serum cholesterol levels in a human consuming the food products without unpleasant effects on the texture of the food products.
  • the present invention provides a composition for use in foods, beverages and nutraceuticals comprising one or more non-sterol emulsifiers, each having an HLB value of greater than 14 and one or more sterols or stanols or mixtures thereof.
  • This invention further provides sterols or stanols or mixtures thereof mixed with one or more non-sterol emulsifiers, each having an HLB value of greater than 14 which are coated and spray dried for optimal food and nutraceutical usage.
  • the present invention further provides a method of reducing and/or preventing the unpleasant organoleptic and sensory qualities (including guminess and waxiness) of the incorporation of sterols and stanols and mixtures thereof into foods, beverages or nutraceuticals which comprises: a) preparing a premix of one or more sterols and/or stanols with one or more high HLB non-sterol emulsifiers; b) adding said premix into the desired food, beverage or nutraceutical.
  • the present invention provides a premix useful for incorporation in a variety of foods, beverages and nutraceuticals comprising one or more non-sterol emulsifiers, each having an HLB value of greater than 14 and one or more sterols or stands or mixtures thereof.
  • the present invention further provides foods, beverages, and nutraceuticals formed with the addition or compositions as provided herein.
  • the present invention further provides a method for treating or preventing CVD and its underlying conditions including atherosclerosis, hypercholesterolemia, hyperlipidemia, hypertension, thrombosis, and related diseases such as Type Il diabetes, as well as other diseases that include oxidative damage as part of the underlying disease process such as dementia, aging, and cancer by administering to an animal foods, beverages or nutraceuticals comprising one or more non-sterol emulsifiers, each having an HLB value of greater than 14 and one or more sterols or stanols or mixtures thereof.
  • the present invention provides a method of preserving a food product from both deterioration due to microbial growth which may be present within said food product, which comprises adding to the food product one or more sterols and/or stanols in combination with one or more non-sterol emulsifiers, each having an HLB value of greater than 14, or mixtures thereof.
  • the present invention further provides a food product comprising an anti- microbiologically effective amount of one or more sterols and/or stanols in combination with one or more non-sterol emulsifiers, each having an HLB value of greater than 14 , or mixtures thereof.
  • the present invention provides a method of reducing the microbial contamination of a particulate food material which comprises mixing into or forming said food material with an anti-microbially effective amount of one or more sterols and/or stanols in combination with one or more non-sterol emulsifiers, each having an HLB value of greater than 14, or mixtures thereof.
  • the present invention provides a prepared food product comprising one or more sterols and/or stanols in combination with one or more non- sterol emulsifiers, each having an HLB value of greater than 14, or mixtures thereof, wherein said food product, after the processing steps to prepare the product and during storage before consumption, contains a reduced number of pathogenic and/or spoilage- causing microbes as compared to the same food product without such addition.
  • SSL was added to milk at a concentration of 0.03% (w/v). Mixture consists of: carrageenan, maltodextrin, ReducolTM and sodium stearoyl lactylate. The mixture was added such that the final concentration in milk was 0.72% (w/v).
  • sterol includes all sterols without limitation, for example: (from any source and in any form: ⁇ , ⁇ and Y) sitosterol, campesterol, stigmasterol, brassicasterol (including dihydrobrassicasterol), desmosterol, chalinosterol, poriferasterol, clionasterol, ergosterol, coprosterol, codisterol, isofucosterol, fucosterol, clerosterol, nervisterol, lathosterol, stellasterol, spinasterol, chondrillasterol, peposterol, avenasterol, isoavenasterol, fecosterol, pollinastasterol, cholesterol and all natural or synthesized forms and derivatives thereof, including isomers.
  • stanol refers to, for example: (from any source and in any form: ⁇ , ⁇ and Y) saturated or hydrogenated sterols including all natural or synthesized forms and derivatives thereof, and isomers, including sitostanol, campestanol, stigmastanol, brassicastanol (including dihydrobrassicastanol), desmostanol, chalinostanol, poriferastanol, clionastanol, ergostanol, coprostanol, codistanol, isofucostanol, fucostanol, clerostanol, nervistanol, lathostanol, stellastanol, spinastanol, chondrillastanol, pepostanol, avenastanol, isoavenastanol, fecostanol, and pollinastastanol.
  • the sterols and stanols for use in forming derivatives in accordance with this invention may be procured from a variety of natural sources or they may be artificially synthesized. For example, they may be obtained from the processing of plant oils (including aquatic plants) such as corn oil and other vegetable oils, wheat germ oil, soy extract, rice extract, rice bran, rapeseed oil, sunflower oil, sesame oil and fish (and other marine-source) oils. They may also be derived from yeasts and fungi, for example ergosterol. Accordingly, the present invention is not to be limited to any one source of sterols.
  • US Patent Serial No. 4,420,427 teaches the preparation of sterols from vegetable oil sludge using solvents such as methanol.
  • phytosterols and phytostanols may be obtained from tall oil pitch or soap, by-products of forestry practises as described in US Patent Serial No.5,770,749, incorporated herein by reference.
  • a further method of extracting sterols and stanols from tall oil pitch is described in Canadian Patent Application Serial No. 2,230,373 which was filed on February 20, 1998 (corresponding to PCT/CA99/00150 which was filed on February 19, 1999) and US Patent Application Serial No 10/060,022 which was filed on January 28, 2002 the contents of all of which are incorporated herein by reference.
  • sterol and "stanol” as used herein, including, but not limited to: free sterols and stanols, esterified sterols and stanols with aliphatic or aromatic acids (thereby forming aliphatic or aromatic esters, respectively), phenolic acid esters, cinnamate esters, ferulate esters, phytosterol and phytostanol glycosides and acylated glycosides or acylglycosides.
  • sterols and “stands” encompasses all analogues, which may further have a double bond at the 5-position in the cyclic unit as in most natural sterols, or one or more double bonds at other positions in the rings (for example, 6, 7, 8(9), 8(14), 14 5/7) or no double bonds in the cyclic unit as in stanols. Further, there may be additional methyl groups as, for example, in ⁇ i -sitosterol.
  • Phytosterols and/or phytostanols once isolated from their source are generally formed into a solid powder through precipitation, filtration and drying, spray drying, lyophilization or by other conventional work-up techniques. It is this powder form which has, heretofore, provided many of the challenges in incorporating phytosterols into various food and beverages matrices i.e. stickiness of the powder, handling difficulties, sensory issues, waxiness, guminess, etc....
  • phytosterols are admixed with one or more high HLB emulsifiers, these handling and other sensory difficulties are overcome.
  • non-sterol emulsifier is intended to encompass high HLB compounds, specifically emulsifiers with an HLB value of equal to or greater than 14.
  • the HLB system is a scale used for describing the characteristics of a surface-active agent. Detailed information on the HLB system and determination of HLB values can be found in the Kirk-Othmer Encyclopedia of Chemical Technology, (3 Ed.) 8: pp 910-918, which is incorporated herein by reference.
  • Emulsifiers having HLB values in the range 7 to 18, especially 8 to 18, are often termed oil in water (o/w) emulsifiers.
  • W/o emulsifiers have HLB values in the range 1-9, especially 1-6. Since HLB numbers are additive, the overall HLB value of a blend of emulsifiers of known HLB can easily be calculated.
  • any non-sterol emulsifier used has an HLB value equal or greater than 17. In another preferred form of the present invention, any non-sterol emulsifier used has an HLB value equal or greater than 20.
  • the most preferred non-sterol emulsifiers for use within this invention are traditional emulsifiers having an HLB in the range of about 16-25. The majority of emulsifiers falling into this category are ethoxylates, most frequently nonionic ethoxylated fatty acids, esters, sorbitan esters, oils and alkylphenols.
  • such emulsifers include alkoxylate emulsifiers with an average of from about 10 to about 100 alkylene oxide, particularly ethylene oxide residues; and non-alkoxylate emulsifiers including sugar mono-esters and poiyglycerol mono-esters, hydrocarbyl, especially alkyl, polysaccharides; fatty acid glycerol esters where the fatty acid has 8 to 12 carbon atoms such as glycerol mono-laurate and fatty acid N-sugar amides such as glucamides.
  • any type of liquid emulsifier meeting the HLB requirement can be used. Examples of other emulsifiers of this type can be found in McCutcheon's, VoI 1 : Emulsifiers & Detergents, 2000, the contents of which are incorporated herein by reference.
  • emulsifiers which may be selected in accordance with the present invention include, but are not limited to: sodium stearoyl lactylate ("SSL" HLB 21), sucrose monostearate, HLB 16; sucrose monolaurate, sodium oleate HLB 18, calcium stearoyl lactylate; sodium oleate (HLB 18); polyoxyethylene-20-sorbitan monopalmitate (HLB 15.6); polyoxyethylene-40-stearate (HLB 16.9); Tween 20 (POE (20) sorbitan monolaurate) (HLB of about 16.7), polyoxyethylene sorbitan monopalmitate, and polyoxyethylene stearic acid monoester. Additionally, EmultopTM may be used.
  • the most preferred non-sterol emulsifier for use within the scope of the present invention is SSL, which can be made by combining lactic acid and stearic acid, and then reacting the result with sodium hydroxide or calcium hydroxide to make the sodium or calcium salt. It is used as an emulsifier in processed foods and as a dough strengthener in baked goods.
  • SSL non-sterol emulsifier
  • a method of reducing and/or preventing the unpleasant organoleptic and sensory qualities (including, but to limited to guminess and waxiness) of the incorporation of sterols and stands and mixtures thereof into foods, beverages or nutraceuticals which comprises: a) preparing a premix of one or more sterols and/or stands with one or more high HLB non-sterol emulsifiers; b) adding said premix into the desired food, beverage or nutraceutical during or after manufacture.
  • the high HLB non-sterol emulsifier and sterol/stanols may be added not as a premix, but as components of the desired food, beverage or nutraceutical matrix during manufacture i.e. not being formed into a separate premix prior to incorporation. It is also contemplated that the selected high HLB non-sterol emulsifier and one or more sterol/stanols may be incorporated into sachets which may be made with specific colourings and/or flavourings and/or sweeteners for use, for example, as a powder to be add to water (by a consumer) to form healthful beverages.
  • compositions, premixes and sachets may be present in the compositions, premixes and sachets and include stabilizers, thickeners, flavourings, vitamins, sweeteners, salt, proteins (dairy, soya etc..) and colouring agents.
  • the high HLB non-sterol emulsifier and sterol/stanols is combined with one or more hydrocolloids.
  • the hydrocolloid is carrageenan, most preferably in kappa form.
  • modified starch is present in the compositions, premixes and sachets of the present invention, the most preferred being maltodextrin.
  • compositions, premixes and sachets of the present invention comprise one or more sterols and or stands, one or more high HLB non-sterol emulsifiers and carrageenan.
  • the compositions, premixes and sachets comprise one or more sterols and or stanols, SSL and carrageenan.
  • the compositions, premixes and sachets comprise one or more sterols and or stanols, SSL, carrageenan and maltodextrin.
  • This premix or the compositions of the high HLB non-sterol emulsifier and sterol/stanols may be added to a wide variety of foods, beverages and nutraceuticals. These include, but are not limited to the following:
  • Fat-Based Products such as margarines, spreads (dairy and non-dairy), peanut butter, peanut spreads, mayonnaise (many of which are formed using emulsions), shortenings, cooking and frying oils and dressings;
  • Grain-based Goods for example, bread and pastas, cookies, pastries, whether these goods are cooked, baked or otherwise processed
  • Confectioneries such as chocolate, candies, chewing gum, desserts, non-dairy toppings (for example Cool WhipTm), sorbets, dairy and non- dairy shakes, icings and other fillings;
  • Miscellaneous Products including processed foods such as soups, pre- prepared pasta sauces, pre-formed meals and the like;
  • Dairy Products butter, dairy spreads, cheeses, yoghurts, yoghurt drinks and beverages such as shakes and any emulsions containing added fat or oils.
  • dairy spreads dairy spreads, cheeses, yoghurts, yoghurt drinks and beverages
  • shakes and any emulsions containing added fat or oils may assist those skilled in the art in identifying various food products into which the premix and compositions of the present invention may be used advantageously.
  • Dairy products a. Milk b. Milk condensed c. Milk evaporated d. Milk powder e. Yogurt (stirred, set, dried etc.) f. Yogurt drink g. Other fermented milk products h. Smoothies i. Cheese i. Hard cheese (Mozzarella, cheddar etc) ii. Soft cheese (Cottage, cream, ricotta etc. j. Cream and cream substitute (fluid and powder) k. Creamers and creamer analogs (fluid and powder) I. Cheese analogs m. Eggnog n. Dairy dips o. Dairy pre-mix (with milk powder, or starch, or protein isolate)
  • Cereals a. Cereal bars b. Cereal-fruit bars c. Breakfast cereals
  • Baking products a. Bread (whole meal, rye, wheat etc.) b. Crisp bread c. Biscuits ⁇ rolls d. Croissants e. Bagels f. Tortillas g. Bread sticks h. Crackers i. Toasts (e.g. melba) j. Cookies k. Muffins
  • Sauces, Dips, Gravies and Condiments a.
  • Sauce paun sauce, pizza sauce, cheese sauce, Hollandaise, tartar, sweet and sour, fish sauce etc.
  • Gravies Gravies (Mushroom, meat etc.)
  • Dips (dairy-based. Non-dairy based, salsa, bean dip etc.)
  • Condiments catsup, marinade, steak sauce, soy, teriyaki etc.
  • Relishes vegetable e.g pickles, fruits e.g. cranberry, avocado
  • Meal replacements a. Snack bars b. Energy bars c. Drinks (eg. Boost, shake) d. Dry mixes e. Protein concentrates (dairy, non-dairy)
  • the high HLB emulsifier clearly improves the mouth feel (bitterness, texture, grainy feel) of phytosterol in a variety of media including in aqueous dispersions or in the aqueous phase of an emulsion.
  • the method and composition of the present invention makes it possible to include phytosterols at effective levels in the aqueous phase of a broad range of comestible products, thereby opening up new formulation opportunities, such as low fat and fat free formulations
  • the means by which the phytosterol/high HLB emulsifier composition will be added to, or incorporated in or on the food product will depend largely on the specific type of food product. It is anticipated that such incorporation will occur at the time of manufacture of the food product, although in many cases, later addition may also be possible.
  • the sterols/stanols are blended with the high HLB emulsifier and then coated (or microencapsulated) with another food grade material. This blending and subsequent coating can be achieved by spray drying or a host of other conventional means. These means include spray drying, fluid bed coating, wet granulation etc...
  • coating materials are suitable: Table 1. Types of coating materials used to produce microcapsules
  • Spray drying is the most used encapsulation method, and is the least expensive.
  • An emulsion is formed between the core and coating, and the emulsion is dried in a hot air drying chamber. This process allows the coating material to trap the core material.
  • the microencapsulation process occurs in a spray dryer, and the process generally involves three steps: first, preparation of the emulsion or dispersion to be processed; second, homogenization of the dispersion; and the last step is atomization of the mass in the drying chamber. Dispersing the active material into the coating material, which is immiscible, makes the dispersion. An emulsifier is then added to the dispersion and the dispersion is then heated and homogenized. This homogenization creates an oil-in- water type of an emulsion. The emulsion is then atomized into a heated air stream supplied to the drying chamber.
  • the sterols/stanols are blended with a high HLB emulsifier such as SSL, and then coated with starch, most preferably modified starch.
  • the sterols/stanols are a powdered composition comprising 30- 75% sitosterol, 2-10% campesterol, 5-20% sitostanol, 2-10 campestanol.
  • phytosterols are preferably administered in very finely divided form. The smaller the particle size the better the dispersion obtained, and the less “sandy" the feeling in the mouth.
  • a low mean particle size e.g. between 10 and 100 microns, preferably lower than 50 microns
  • the phytosterol/high HLB emulsifier composition may be solubilized or dispersed in emulsions, suspensions, solutions, solid dispersions, macroemulsions, microemulsions, self-emulsifying systems, hydrated lipid systems, formed into inclusion complexations with cyclodextrins or bile salts or formed into hydrotopes.
  • the phytosterol/high HLB emulsifier composition is primarily localized to the water phase of an emulsion.
  • the emulsified fat based products created in accordance with the invention may be oil-in- water (o/w, or water continuous) or water-in-oil (w/o, or oil continuous) emulsions according to which specific emulsifiers may be are selected for use in preparing the emulsion. Water in oil (w/o or oil continuous emulsions) are most preferred.
  • enteral pharmaceutical and nutritional products such as edible spreads, margarines, and icings/frostings it is usual to generate a w/o emulsion.
  • ReducolTM (Phytosource) 0.24 (Reducol is a compostion of phytosterols and phytostanols)
  • Reducol is a mixture of phytosterols and phytostanols (primarily sitosterol, sitostanol, campesterol, campestanol) extracted from forestry by-products.
  • Lecithin Leciprime 1800 IPM, Cargill
  • Lecithin Leciprime 1800 IPM, Cargill
  • the premix obtained above is water dispersible, as opposed to free phytosterols/phytostanols (such as ReducolTM) alone, as they are completely hydrophobic).
  • This premix can therefore be incorporated in a variety of liquid food and beverage matrices such as, for example: milk and milk-based beverages, fruit juices, water, etc...
  • ReducolTM:SSL from 10:1 (for example ReducolTM 3% & SSL 0.3%) to 43.3:1 (for example: ReducolTM13% & SSL 0.3%;)
  • ReducolTM:Carrageenan from 187.5:1 (for example:. ReducolTM 3% & Carrageenan 0.016%) to 812.5:1 (for example: ReducolTM 13% & Carrageenan 0.016%)
  • SSL:Carrageenan 18.75:1 for example: SSL 0.3% & Carrageenan 0.016%).
  • One particular advantage of this formulation is the fact that it significantly simplifies the procedure of preparation of the orange juice drink, eliminating the steps required to dissolve the stabilizers and disperse the ReducolTM uniformly throughout the liquid.
  • SSL K Emplex 268508104, AIC 0.300 Carageenan (CM 750, Food Specialties) 0.160
  • ReducolTM may be added either to the binder phase entirely (up to -6%), or may be split between the two phases
  • the ingredients are prepared as per example 4.
  • the ingredients are prepared as per example 4.
  • the ingredients are prepared as per example 1.
  • the resultant product "Reducol Plus 500" contains 5% SSL, 5% Pure-Cote and 93% Reducol.
  • the resultant product "Reducol Plus 200" contains 2% CSL, 5% Pure-Cote and 93% Reducol.
  • SSL is an anionic lipophilic emulsifier (Ultra Chemical Inc, 2000) its ability to ostensibly disperse ReducolTM would be advantageous as the efficacy of hydrophobic antimicrobials is dependant on their ability to travel across the aqueous phase of a solution in order to interact with the membrane of the target organism.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Cardiology (AREA)
  • Microbiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Obesity (AREA)
  • Mycology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dairy Products (AREA)
  • Edible Oils And Fats (AREA)
  • Steroid Compounds (AREA)

Abstract

L'invention concerne une composition à utiliser dans des produits alimentaires, des boissons et des produits nutraceutiques, qui comprend : a) un ou plusieurs émulsifiants non stéroliques, chacun présentant une valeur HLB supérieure à 14 ; et un ou plusieurs stérols ou stanols ou mélanges de ceux-ci.
PCT/CA2006/002077 2005-12-20 2006-12-20 Compositions comprenant un ou plusieurs phytostérols et/ou phytostanols, ou des dérivés de de ceux-ci, et des émulsifiants à rapport hlb élevé WO2007071038A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2008546053A JP2009519721A (ja) 2005-12-20 2006-12-20 １種又はそれ以上のフィトステロール及び／又はフィトスタノール、又はその誘導体、及び高ｈｌｂ乳化剤を含む組成物。
EP06840504A EP1973427A2 (fr) 2005-12-20 2006-12-20 Compositions comprenant un ou plusieurs phytostérols et/ou phytostanols, ou des dérivés de de ceux-ci, et des émulsifiants à rapport hlb élevé
CA002673010A CA2673010A1 (fr) 2005-12-20 2006-12-20 Compositions comprenant un ou plusieurs phytosterols et/ou phytostanols, ou des derives de de ceux-ci, et des emulsifiants a rapport hlb eleve
AU2006326830A AU2006326830A1 (en) 2005-12-20 2006-12-20 Compositions comprising one or more phytosterols and/or phytostanols, or derivatives thereof, and high HLB emulsifiers

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US75187805P 2005-12-20 2005-12-20
US60/751,878 2005-12-20
US79074906P 2006-04-10 2006-04-10
US60/790,749 2006-04-10

Publications (2)

Publication Number Publication Date
WO2007071038A2 true WO2007071038A2 (fr) 2007-06-28
WO2007071038A3 WO2007071038A3 (fr) 2007-10-18

Family

ID=38189002

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CA2006/002077 WO2007071038A2 (fr) 2005-12-20 2006-12-20 Compositions comprenant un ou plusieurs phytostérols et/ou phytostanols, ou des dérivés de de ceux-ci, et des émulsifiants à rapport hlb élevé

Country Status (6)

Country Link
EP (1) EP1973427A2 (fr)
JP (1) JP2009519721A (fr)
KR (1) KR20090006051A (fr)
AU (1) AU2006326830A1 (fr)
CA (1) CA2673010A1 (fr)
WO (1) WO2007071038A2 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010084240A1 (fr) 2009-01-26 2010-07-29 Raisio Nutrition Ltd Boisson réduisant le cholestérol sérique
CN102448330A (zh) * 2009-02-23 2012-05-09 托马斯·弗朗西斯·哈廷格莱德 植物甾醇分散体
AU2007327973B2 (en) * 2006-12-04 2013-05-23 Cognis Ip Management Gmbh Method for producing sterol formulations
CN104822276A (zh) * 2012-11-07 2015-08-05 理研维他命股份有限公司 粉末状植物甾醇组合物及其制造方法

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6092579B2 (ja) * 2012-11-07 2017-03-08 理研ビタミン株式会社 粉末状植物ステロール組成物およびその製造方法
JP6092580B2 (ja) * 2012-11-07 2017-03-08 理研ビタミン株式会社 粉末状植物ステロール組成物およびその製造方法
JP2015047080A (ja) * 2013-08-30 2015-03-16 株式会社ファンケル 乳化組成物
RU2726453C2 (ru) * 2014-03-03 2020-07-14 Райсио Нутришн ЛТД Пищевой продукт, снижающий содержание сывороточного холестерина
KR200483033Y1 (ko) 2015-09-21 2017-03-27 (주)세양아트 천장식 빨래 건조대

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0897671A1 (fr) * 1997-08-22 1999-02-24 Unilever N.V. Dispersions ou suspensions aqueuses
US6063776A (en) * 1998-05-26 2000-05-16 Washington University Sitostanol formulation with emulsifier to reduce cholesterol absorption and method for preparing and use of same
US6267963B1 (en) * 1999-06-02 2001-07-31 Kraft Foods, Inc. Plant sterol-emulsifier complexes
US6274574B1 (en) * 1999-02-26 2001-08-14 Kraft Foods, Inc. Use of mesophase-stabilized compositions for delivery of cholesterol-reducing sterols and stanols in food products
EP1142494A1 (fr) * 2000-04-06 2001-10-10 Kraft Foods, Inc. Microbroyage de stéroles de plantes et d'émulsifiants
WO2003055324A1 (fr) * 2001-12-21 2003-07-10 Raisio Benecol Oy Composition contenant un hydrolysat de proteines et un sterol vegetal servant a ameliorer le profil de lipide serique et a prevenir l'atherosclerose
WO2003077680A1 (fr) * 2002-03-20 2003-09-25 Eugene Science Inc. Melange poudreux de sterol vegetal et d'emulsifiant, et procede de preparation associe

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5932562A (en) * 1998-05-26 1999-08-03 Washington University Sitostanol formulation to reduce cholesterol absorption and method for preparing and use of same
US6123978A (en) * 1998-08-31 2000-09-26 Mcneil-Ppc, Inc. Stable salad dressings
US6677327B1 (en) * 1999-11-24 2004-01-13 Archer-Daniels-Midland Company Phytosterol and phytostanol compositions
GB0021498D0 (en) * 2000-09-01 2000-10-18 Novartis Nutrition Ag New formulation
GB0104074D0 (en) * 2001-02-19 2001-04-04 Novartis Ag New composition

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0897671A1 (fr) * 1997-08-22 1999-02-24 Unilever N.V. Dispersions ou suspensions aqueuses
US6063776A (en) * 1998-05-26 2000-05-16 Washington University Sitostanol formulation with emulsifier to reduce cholesterol absorption and method for preparing and use of same
US6274574B1 (en) * 1999-02-26 2001-08-14 Kraft Foods, Inc. Use of mesophase-stabilized compositions for delivery of cholesterol-reducing sterols and stanols in food products
US6376482B2 (en) * 1999-02-26 2002-04-23 Kraft Foods, Inc. Use of mesophase-stabilized compositions for delivery of cholesterol-reducing sterols and stanols in food products
US6267963B1 (en) * 1999-06-02 2001-07-31 Kraft Foods, Inc. Plant sterol-emulsifier complexes
EP1142494A1 (fr) * 2000-04-06 2001-10-10 Kraft Foods, Inc. Microbroyage de stéroles de plantes et d'émulsifiants
WO2003055324A1 (fr) * 2001-12-21 2003-07-10 Raisio Benecol Oy Composition contenant un hydrolysat de proteines et un sterol vegetal servant a ameliorer le profil de lipide serique et a prevenir l'atherosclerose
WO2003077680A1 (fr) * 2002-03-20 2003-09-25 Eugene Science Inc. Melange poudreux de sterol vegetal et d'emulsifiant, et procede de preparation associe

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007327973B2 (en) * 2006-12-04 2013-05-23 Cognis Ip Management Gmbh Method for producing sterol formulations
WO2010084240A1 (fr) 2009-01-26 2010-07-29 Raisio Nutrition Ltd Boisson réduisant le cholestérol sérique
US9295267B2 (en) 2009-01-26 2016-03-29 Raisio Nutrition Ltd Beverage lowering serum cholesterol
CN102448330A (zh) * 2009-02-23 2012-05-09 托马斯·弗朗西斯·哈廷格莱德 植物甾醇分散体
JP2012518628A (ja) * 2009-02-23 2012-08-16 フランシス ハーティンググレイド，トーマス フィトステロール分散体
CN104822276A (zh) * 2012-11-07 2015-08-05 理研维他命股份有限公司 粉末状植物甾醇组合物及其制造方法

Also Published As

Publication number Publication date
EP1973427A2 (fr) 2008-10-01
JP2009519721A (ja) 2009-05-21
KR20090006051A (ko) 2009-01-14
CA2673010A1 (fr) 2007-06-28
AU2006326830A1 (en) 2007-06-28
WO2007071038A3 (fr) 2007-10-18

Similar Documents

Publication Publication Date Title
US8309156B2 (en) Compositions comprising one or more phytosterols and/or phytostanols, or derivatives thereof, and high HLB emulsifiers
EP1227734B1 (fr) Compositions contenant des huiles ou des graisses comestibles ainsi que des phytost rols et/ou des phytostanols dissous
JP4562352B2 (ja) コレステロール低下用改良食用組成物類
WO2007071038A2 (fr) Compositions comprenant un ou plusieurs phytostérols et/ou phytostanols, ou des dérivés de de ceux-ci, et des émulsifiants à rapport hlb élevé
KR101007423B1 (ko) 혈청 지질 프로필을 개선하고 아테롬성동맥경화증을예방하기 위한 단백질 가수분해물 및 식물 스테롤을함유하는 조성물
JP3574812B2 (ja) 脂肪混合物の製造方法
EP2399463B1 (fr) Dispersion de phytostérols
JPH11146757A (ja) 水性分散液又は懸濁液
JP2001502168A (ja) 製品、その製造方法およびその使用方法
US20070254088A1 (en) Composition comprising one or more esterified phytosterols and/or phytostanols into which are solubilized one or more unesterified phytosterols and/or phytostanols, in order to achieve therapeutic and formulation benefits
US20070141123A1 (en) Emulsions comprising non-esterified phytosterols in the aqueous phase
WO2019129929A1 (fr) Composition alimentaire comprenant des stérols et/ou des stanols végétaux, sa production et son utilisation
JP2013129671A (ja) ステロール含有粉末

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2008546053

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2006326830

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 1020087017215

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 569863

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 2006840504

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2006326830

Country of ref document: AU

Date of ref document: 20061220

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2006326830

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 2006840504

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2673010

Country of ref document: CA